Question Everything. See who's reporting it.

Kerala switches to generic SMA drug Natsmart

Source: The Hindu

The story in brief

In February 2026, the Keralam government approved Natsmart, a generic version of Risdiplam, to manage spinal muscular atrophy. The regulator stated bioequivalence studies are unnecessary, dismissing claims of efficacy concerns as baseless. Despite cost savings, some parents urge a return to the branded drug.

NEWXFree on Android and iPhone. Open in NEWX